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Abstract: Traffic noise has been linked to diabetes, with limited understanding of its mechanisms.
We hypothesize that night-time road traffic noise (RTN) may impair glucose homeostasis through
circadian rhythm disturbances. We prospectively investigated the relationship between residential
night-time RTN and subsequent eight-year change in glycosylated hemoglobin (∆HbA1c) in
3350 participants of the Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in
Adults (SAPALDIA), adjusting for diabetes risk factors and air pollution levels. Annual average
RTN (Lnight) was assigned to participants in 2001 using validated Swiss noise models. HbA1c
was measured in 2002 and 2011 using liquid chromatography. We applied mixed linear models
to explore RTN–∆HbA1c association and its modification by a genetic risk score of six common
circadian-related MTNR1B variants (MGRS). A 10 dB difference in RTN was associated with a
0.02% (0.003–0.04%) increase in mean ∆HbA1c in 2142 non-movers. RTN–∆HbA1c association was
modified by MGRS among diabetic participants (Pinteraction = 0.001). A similar trend in non-diabetic
participants was non-significant. Among the single variants, we observed strongest interactions with
rs10830963, an acknowledged diabetes risk variant also implicated in melatonin profile dysregulation.
Night-time RTN may impair glycemic control, especially in diabetic individuals, through circadian
rhythm disturbances. Experimental sleep studies are needed to test whether noise control may help
individuals to attain optimal glycemic levels.
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1. Introduction
Glycosylated hemoglobin (HbA1c) reflects three-month average glycemia [1], predicts diabetes in
non-diabetic individuals, and complications in diabetic individuals [2,3]. Despite control efforts, the
prevalence of poorly-controlled diabetes remains high [4]. Recent interest in the role of environmental
stressors in cardio-metabolic diseases towards improved prevention [5] makes it pertinent to explore
the environmental determinants of glycemic control. Hyperglycemia is an important risk factor
for cardiovascular diseases [6–8] and diabetes [2,3]. Understanding the role of environmental
stressors also entails investigations of their mediating or modifying mechanisms, in persons with and
without diabetes.
Road traffic noise (RTN) represents the most common transportation noise, and together with
air pollution, constitutes more than 75% of environmental disease burden in Europe [9]. Growing
evidence suggests a link between RTN and diabetes morbidity [10–14] and mortality [15] (independent
of traffic-related air pollution), with unclear mechanisms [5,16].
Melatonin, a pineal hormone known to act on numerous organs and co-regulate various neural
and endocrine processes, exhibits a circadian rhythm which is closely linked to sleep propensity [17]
and insulin secretion [18]. Administration of exogenous melatonin elicited subjective sleepiness [19]
and glucose intolerance when given close to mealtime [20]. Melatonin mediates its regulatory
function through binding to receptors including the high-affinity melatonin receptor 1B encoded by
MTNR1B, a gene widely expressed in the human retina and pancreatic islet cells. Recent genome-wide
association studies (GWAS) showed seven common variants near MTNR1B to be associated with
glucose homeostasis or type 2 diabetes, mainly through impairments in insulin secretion [21]. The
glucose-raising allele of the lead variant, rs10830963, was shown to significantly prolong the duration
of elevated melatonin levels by 41 min, and delayed the circadian phase of dimlight melatonin offset
by 1.37 h, as well as increased diabetes risk among individuals who woke up early [22]. Individuals
who are evening chronotypes were also shown to have higher risk of diabetes [23]. In both instances,
it is thought that waking up early or sleeping late (during high melatonin and low insulin phase)
predisposes to having meals, leads to high insulin levels and subsequent hyperglycemia, as a result of
altered timing of food intake. Thus, the glucose-raising allele of rs10830963 could modify susceptibility
to noise exposure in cases of early awakenings during melatonin secretion (Figure 1).
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Figure 1. Hypothesized mechanisms of noise effects on glucose homeostasis explored in the
present study.
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Night-time noise exposure could impair glucose homeostasis through disturbances in circadian
sleep–wake cycles. Circadian pathway was captured using melatonin-regulating genetic variants as a
proxy, possibly reflecting genetic risk for melatonin profile dysregulation.
Although there are at least seven common variants on MTNR1B influencing glucose metabolism
through a common pathway [21], sleep and circadian studies have only focused on rs10830963
variant [24]. In essence, following the approach of using scores involving multiple variants for
improved prediction of genetic risks [25,26], an MTNR1B genetic risk score (MGRS) based on variants
that are not in strong linkage disequilibrium (LD), may better capture individuals at high-risk of
melatonin profile dysregulation than single variants.
Understanding the implications of noise exposure on glucose homeostasis through interactions
with circadian-related parameters will improve our understanding and offer preventive channels
towards optimal glucose control in diabetic and non-diabetic individuals.
We therefore tested the hypothesis that MGRS (and component single variants representing the
circadian pathway) may modify the potential association between night-time RTN and eight-year
change in HbA1c (∆HbA1c) in diabetic and non-diabetic participants of the Swiss Cohort Study on Air
Pollution and Lung and Heart Diseases in Adults (SAPALDIA).
2. Materials and Methods
2.1. Study Population
Participants included 3350 adults aged 29–81 years who completed health interviews and
examinations at the first (SAP2) and second (SAP3) SAPALDIA follow-up surveys, and had
complete information on relevant covariates. Details of inclusion are shown in Figure S1.
The SAPALDIA study began in 1991 (SAP1), with 9651 randomly-selected adults from eight
geographically-representative Swiss areas [27]. Two follow-up surveys in 2001/2002 and 2010/2011
retained 8047 and 6088 participants, respectively. At each survey, participants responded to detailed
questions concerning their health and lifestyle. At SAP2 and SAP3, blood was sampled into a biobank
for biomarker assays, including HbA1c and genotyping. Participants provided written informed
consent and ethical clearances were obtained from the Ethics Committees of the Swiss Academy of
Medical Sciences and the participating cantons (National Ethics Committee for Clinical Research
(UREK); Project Approval Number 123/00; date of approval: September 2001).
2.2. Measurement of HbA1c and Identification of Diabetes Cases
HbA1c was measured in EDTA-buffered whole blood samples collected at SAP2 and SAP3 using
the ARK-RAY ADAMS A1c HA-8180V Analyser (Menarini, Florence, Italy) based on high-performance
liquid chromatography, which has minimal interference from alternate hemoglobin variants [28].
HbA1c values were measured in mmol/mol, and converted into percentage [29]. Using a combination
of questionnaire data and HbA1c values, we identified participants as diabetes cases if they
(I) self-reported physician-diagnosed diabetes, (II) used diabetes medication, or (III) had a HbA1c value
≥6.5% at SAP2 or SAP3. We also defined confirmed/advanced diabetes, restricted to only participants
taking medication, thus, yielding three comparative groups: no diabetes (at SAP2 and SAP3), diabetes
(at SAP2 or SAP3), and diabetes on medication (at SAP2 or SAP3). We defined ∆HbA1c as the absolute
difference between HbA1c at SAP3 (2011) and HbA1c at SAP2 (2002).
2.3. Exposures
Average annual exposure to RTN was assigned to participants based on the most exposed
façade of their residential floors in 2001 and 2011 (corresponding to the survey time points) using the
SonROAD emission and STL-86 propagation models combining high-resolution spatial and temporal
road traffic information, as previously described [30]. This was done in the framework of the SiRENE
(Short and Long-Term Effects of Transportation Noise Exposure) project, where railway and aircraft
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noise were also assigned to the same façade using sonRAIL propagation and SEMIBEL emission
models for railway noise, and FLULA2 simulation model for aircraft noise—all validated Swiss noise
models [30]. Day (Lday; 07–23 h), night (Lnight; 23–07 h), and day–evening–night (Lden) noise (dB)
were computed for road, railway, and aircraft sources. Participants without substantial night-time
railway/aircraft exposures were assigned truncated values of 20 dB, and were assigned a truncation
indicator. Lnight was highly correlated with constituent time points (23–01 h, 01–05 h and 05–07 h;
Spearman R > 0.9). Day and night-time correlations (Spearman R) of road traffic, aircraft, and railway
noise were 0.99, 0.33, and 0.93, respectively. Since our study was aimed at modification of noise–HbA1c
association by circadian-related parameters, and RTN is the most common noise with consistently
reported associations with diabetes mortality/morbidity [12], we focused our analyses on night-time
RTN, considering night-time railway and aircraft noise as potential confounders, with secondary
exploration of their main associations. Noise levels were quite stable over follow-up (Spearman R > 0.9
for both time points), thus, the noise levels at 2001 would capture long-term exposures in statistical
models predicting health outcomes after 2001. To limit exposure misclassification to an extent, we
also restricted analyses to SAPALDIA participants who did not change their residence during the
follow-up period.
2.4. Potential Confounders
From the questionnaire data at SAP2, we extracted additional potential confounders of the
association between RTN at SAP2 and change in HbA1c between SAP2 and SAP3. These included
age (continuous), sex (male/female), formal education (≤9 (primary level)/10–13 (secondary,
apprenticeship level)/>13 years (tertiary level)), neighborhood socio-economic index (SEI) (continuous;
incorporating education and income of household head, median rent and crowding of households
within the neighborhood) [31], and green areas within 2 km residential buffer, available from the
European Environment Agency hectare resolution dataset (continuous; CORINE CLC-2006 Version 13).
We also considered smoking status (never/former/current), exposure to passive smoke (yes/no),
consumption of alcohol (including liquor, wines, beers and spirits; ≤1/>1 glass/day), and body mass
index (BMI), defined as weight and height-squared ratio (continuous). Towards sensitivity analyses,
we extracted participants’ responses to the question “do you often feel that you have not slept enough
after you wake up in the morning?” from which we derived insufficient sleep (yes/no), as well as their
responses to the Short Form 36-item mental health questionnaire (continuous) [32]. In SAP2, average
annual residential exposure to nitrogen dioxide (NO2), a marker of road traffic-related air pollution
and potential confounder of RTN [33], was assigned to participants’ residences based on a hybrid
model (adjusted R2 = 0.83) derived by fitting NO2 sampler measurements using land-use and traffic
variables, and predictions from a Gaussian dispersion model as previously described [34].
2.5. MTNR1B Gene Score
Genomic DNA was extracted from EDTA-buffered whole blood using Puragene™ DNA Isolation
Kit (Gentra Systems, Plymouth, UK). Genotyping of SAPALDIA participants was done on DNA
samples collected at SAP2. In the framework of the EU-funded GABRIEL consortium to identify
genetic determinants of asthma [35], 1612 participants were genotyped using Illumina Human
610Kquad BeadChip (G1; Illumina, San Diego, CA, USA) covering ~570,000 variants. An additional
3015 participants were genotyped using Illumina Human OmniExpress-Exome BeadChip (G2; Illumina,
San Diego, CA, USA), covering ~1 million variants. Quality control criteria were applied to both
genotyping arrays: samples with <97% genotyping success rate, or of non-European origin, with
cryptic relatedness or sex inconsistencies, were excluded. Variants with minor allele frequency (MAF)
of <5% or deviation from Hardy–Weinberg equilibrium (HWE) at a threshold of 10−6 were also
excluded. G1 and G2 datasets were phased using ShapeIT version 2.r790 [36] and imputed using
MiniMac2 [37]. The imputed datasets were then merged, after excluding variants with low imputation
quality (R2 < 0.3), yielding ~14 million markers for 4324 participants across G1 and G2, from where we
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identified seven common MTNR1B variants (rs1387153, rs10830962, rs4753426, rs8192552, rs10830963,
rs3781638 and rs2166706) involved in glucose dysregulation [21]. Imputations were of high quality.
All but rs10830963 (R2 ≥ 0.87) had an imputation R2 ≥ 0.92. All variants had similar allele frequencies
in comparison with other studies [38–49] and the 1000 Genomes Central European Population [50].
All variants were in HWE (p > 0.2), with MAF≥ 7% (Table S1). Two variants, rs10830962 and rs2166706,
were in high LD (R2 = 0.89; Figure S2), thus, we excluded rs2166706 from the analyses. The LD R2
of the included MTNR1B variants ranged between 0.2 and 0.7. Since the glucose-raising allele of
rs10830963 was the allele implicated in melatonin profile dysregulation, expressed as a significant
delay in melatonin offset [22], we coded the other variants in their reported direction of association in
glucose alterations, such that each variant contained 0–2 quantities of the risk allele. We created MGRS
by summing up risk alleles across the six variants, yielding a minimum, median, and maximum of 2, 6,
and 12 risk alleles, respectively. We also created a categorical variable—low risk (MGRS ≤ 6) and high
risk (>6).
2.6. Statistical Analyses
We summarized the characteristics of participants by inclusion and exclusion status. Differences
in proportions and means were tested using chi-squared and t-tests respectively. We built predictive
statistical models using noise exposure and covariates measured at SAP2, for ∆HbA1c. Both crude and
adjusted associations between MGRS (as well as the single variants, in separate models) and ∆HbA1c;
and between RTN and ∆HbA1c were assessed using mixed linear models with a random intercept at
the level of study area. Adjusted models included age, sex, education, neighborhood SEI, smoking
status, alcohol consumption, and BMI. Adjusted RTN–∆HbA1c models additionally included NO2,
railway and aircraft noise, noise truncation indicators, and green space within a 2 km residential buffer.
We included interaction terms between RTN and MGRS (as well as the single variants, in separate
models), in the RTN–∆HbA1c models, to explore the presence of interactions between these variables.
We also stratified the RTN–∆HbA1c model by categories of MGRS. Furthermore, we restricted analyses
to participants who did not change their residence during follow-up. Since our study included only
35% of SAP1 participants, we limited potential selection bias by applying the inverse of the probability
of participating in present analyses as weights in our models. These probability weights were derived
from a logistic regression model using predictor variables from SAP1. We performed sensitivity
analyses: we explored cross-sectional associations between MGRS (as well as the single variants,
in separate models) and HbA1c using repeated mixed linear models with random intercepts at the
level of participants. Using the RTN–∆HbA1c model, we tested sensitivity to removal of BMI from
the main and interaction models, performed complete case analyses without adjusting for potential
selection bias, and excluded asthmatic participants in the RTN–MGRS interaction model to explore
potential genotyping selection bias. We explored interactions with self-reported sleep insufficiency
reported at SAP2. All analyses were stratified into three categories—no diabetes, diabetes, and
diabetes on medication—to limit confounding/effect modification by diabetes status or medication.
All analyses were done using STATA version 14 (STATA Corporation, College Station, TX, USA).
Statistical significance was defined at two-sided alpha-values of 0.05 and 0.1 for main associations and
interactions, respectively.
3. Results
3.1. Characteristics of Participants
Over an approximate eight-year follow-up, the mean increase in HbA1c was 0.04%, whereas
diabetes prevalence was 3% at SAP2 and 7% at SAP3, with 8% combined prevalence in the
3350 included participants. On average, diabetic participants gained more HbA1c than non-diabetic
participants (Table 1), in line with evidence for poor glucose control in Switzerland [51].
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Table 1. Characteristics of study participants included in the study.
Categorical Variables (%)
Females at SAP2 48
Formal education at SAP2: ≤9 years 4
10–13 years 64
>13 years 32
Ever-smoker at SAP2 55
Exposure to passive smoke at SAP2 23
Alcohol consumption >once/day at SAP2 40
Sleep insufficiency at SAP2 28
Diabetes status at SAP2 3
Diabetes status at SAP3 7
Diabetes medication at SAP2 3
Diabetes medication at SAP3 5
Change of residence (movers) between SAP2 and SAP3 36
Continuous Variables (Units) Mean (SD)
Age at SAP2 (years) 51 (11)
Body mass index at SAP2 (kg/m2) 25.6 (4)
Neighborhood socio-economic index at SAP2 (%) 64 (10)
SF-36 mental health score at SAP2 (%) a 76 (15)
Lnight, road at SAP2 (dB) 45.8 (8)
Lnight, railway at SAP2 (dB) 28.3 (10)
Lnight, aircraft at SAP2 (dB) 22.7 (6)
Nitrogen dioxide at SAP2 (µg/m3) 22.4 (10)
Green space within 2 km radius at SAP2 (km2) 0.3 (0.4)
MTNR1B variants at SAP2: rs1387153, T allele 0.6 (0.6)
rs10830962, G allele 0.8 (0.7)
rs4753426, C allele 1.0 (0.7)
rs8192552, G allele 1.9 (0.4)
rs10830963, G allele 0.6 (0.6)
rs37816938, G allele 1.1 (0.7)
MTNR1B genetic risk score at SAP2 6 (3)
Glycosylated hemoglobin, HbA1c at SAP2 (%) 5.2 (0.4)
HbA1c at SAP3 (%) 5.3 (0.5)
Change in HbA1c between SAP2 and SAP3 (%): All 0.04 (0.4)
Non-diabetic participants 0.03 (0.3)
Diabetic participants 0.17 (1.1)
Diabetic participants on medication 0.12 (1.2)
a N (included) = 2933.
SAP2 and SAP3 represent the first and second follow-up surveys of the Swiss Cohort Study on
Air Pollution and Lung and Heart Diseases in Adults in 2002 and 2010/2011, respectively. Lnight
represents night-time (23–07 h) noise levels assigned to the SAPALDIA participants based on the most
exposed façade of their residential floors. Number of included participants is 3350.
Mean (SD) annual exposures to night-time road traffic, railway, and aircraft noise at SAP2 were
46 (8) dB, 28 (10) dB, and 23 (6) dB, respectively. Figure S3 shows the distribution of noise exposures
in the included participants. Mean (SD) MGRS was 6 (3) risk alleles. Compared to the participants
excluded due to non-participation during follow-up or missing data, included participants were
younger, more likely males, better educated, and less likely to be overweight or diabetic. They also
had lower exposure to RTN and NO2, but higher exposure to aircraft noise. There were no significant
differences in ∆HbA1c, MGRS, and change of residence between both groups (Table S2).
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3.2. Associations between RTN and ∆HbA1c
In non-diabetics, we observed generally non-significant associations between transportation noise
and ∆HbA1c. Among diabetics, associations with railway and aircraft noise were positive (reaching
significance only for aircraft noise), whereas associations with road traffic noise were negative. Limiting
analyses to non-movers revealed consistent positive associations between RTN and ∆HbA1c among
both diabetic and non-diabetic participants. Among non-diabetic non-movers, mean ∆HbA1c showed
a statistically significant increase by 0.01% (95% CI 0, 0.03) per 10 dB exposure to RTN. Among diabetic
non-movers, associations were reversed compared to all participants, became positive, and were
stronger than we observed in non-diabetic participants. Associations also reached ten-fold in those
reporting the use of diabetic medication compared to non-diabetics, but were not significant (Table 2).
All estimates represent increase (+) or decrease (−) in mean change in HbA1c per 10 dB
of night-time road traffic noise. Adjusted models included age, sex, education, neighborhood
socio-economic index, smoking status, passive smoking, alcohol consumption, green space within a
2 km residential buffer, residential levels of nitrogen dioxide, night-time railway, aircraft noise and their
truncation indicators. All models include random intercepts at the level of the study areas, and were
adjusted for potential selection bias by applying the probability of participation in present analyses as
weights derived from a logistic regression with predictors from the baseline study in 1991.
In the adjusted models, we also found significantly positive associations of ∆HbA1c with
aircraft noise in non-diabetics, where mean HbA1c increased by 0.02% (95% CI 0, 0.03) per 10 dB
difference in Lnight. There were no significant associations with railway noise. Similar to RTN,
associations of ∆HbA1c with aircraft noise in non-movers were consistently positive across comparison
groups (Table 2). All models were stable to confounder adjustments, including BMI. Irrespective of
subpopulation studied or confounder adjustments, we did not observe any association of railway
noise with ∆HbA1c.
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Table 2. Exposure to night-time transportation noise in 2001 (10 dB difference) and subsequent change in HbA1c (%).
All
Participants Source Model
All
N = 3350
No Diabetes
N = 3098
Diabetes
N = 251
Diabetes on Medication
N = 168
β (95% CI) β (95% CI) β (95% CI) β (95% CI)
Road
Crude 0.01 (−0.01, 0.03) 0.01 (0.002, 0.02) * −0.02 (−0.22, 0.18) −0.03 (−0.25, 0.18)
Adjusted 0.01 (−0.02, 0.03) 0.01 (−0.0004, 0.02) † −0.07 (−0.26, 0.11) −0.13 (−0.36, 0.10)
Adjusted+BMI 0.01 (−0.02, 0.03) 0.01 (−0.001, 0.02) † −0.08 (−0.27, 0.11) −0.11 (−0.35, 0.15)
Railway
Crude 0.004 (−0.01, 0.02) 0.003 (−0.01, 0.01) 0.03 (−0.06, 0.12) 0.03 (−0.11, 0.16)
Adjusted 0.001 (−0.01, 0.02) 0.001 (−0.01, 0.01) 0.01 (−0.05, 0.08) 0.05 (−0.05, 0.13)
Adjusted+BMI 0.002 (−0.01, 0.02) 0.001 (−0.01, 0.01) 0.02 (−0.05, 0.08) 0.04 (−0.04, 0.12)
Aircraft
Crude −0.0003 (−0.01, 0.01) −0.01 (−0.03, 0.01) 0.24 (−0.08, 0.55) 0.26 (0.05, 0.47) *
Adjusted 0.005 (−0.02, 0.03) −0.004 (−0.03, 0.02) 0.34 (0.12, 0.55) † 0.34 (0.13, 0.54) †
Adjusted+BMI 0.01 (−0.01, 0.02) −0.003 (−0.02, 0.02) 0.35 (0.08, 0.62) † 0.31 (0.03, 0.60) †
Non-movers Source Model AllN = 2142
No Diabetes
N = 1960
Diabetes
N = 179
Diabetes on Medication
N = 117
Road
Crude 0.02 (0, 0.04) * 0.01 (0.0004, 0.03) * 0.06 (−0.21, 0.33) 0.07 (−0.26, 0.39)
Adjusted 0.02 (0.003, 0.04) * 0.01 (0, 0.03) * 0.04 (−0.16, 0.24) 0.10 (−0.13, 0.33)
Adjusted+BMI 0.02 (0.003, 0.04) * 0.01 (0, 0.03) * 0.03 (−0.14, 0.19) 0.10 (−0.09, 0.29)
Railway
Crude 0.001 (−0.03, 0.03) −0.01 (−0.02, 0.01) 0.06 (−0.15, 0.26) 0.05 (−0.31, 0.41)
Adjusted −0.001 (−0.03, 0.03) −0.01 (−0.02, 0.01) 0.02 (−0.29, 0.31) −0.03 (−0.53, 0.47)
Adjusted+BMI −0.001 (−0.03, 0.03) −0.01 (−0.02, 0.01) 0.02 (−0.24, 0.29) −0.03 (−0.46, 0.40)
Aircraft
Crude 0.03 (0.01, 0.05) 0.01 (−0.01, 0.03) 0.24 (−0.04, 0.53) † 0.22 (−0.03, 0.47) †
Adjusted 0.04 (0.01, 0.07) † 0.02 (−0.002, 0.03) † 0.30 (−0.15, 0.74) 0.14 (−0.44, 0.71)
Adjusted+BMI 0.04 (0.01, 0.07) † 0.02 (0, 0.03) * 0.32 (−0.22, 0.86) 0.13 (−0.49, 0.74)
* p < 0.05; † p < 0.1.
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3.3. Associations between MGRS and ∆HbA1c
Results of main associations between MGRS (and component variants) and HbA1c are presented
in Table S4. In non-diabetic participants, MGRS showed a positive association with ∆HbA1c and
cross-sectional HbA1c, but only reached significance in the cross-sectional analysis. All six single
variants were positively associated with HbA1c, with associations of 0.01–0.03% per risk allele. Among
diabetic participants, there was a non-significant tendency for associations of MGRS (and component
variants) with ∆HbA1c and cross-sectional HbA1c to be negative.
3.4. Modification of RTN-∆HbA1c Association by MGRS
Among non-movers, we observed significant interactions between MGRS and RTN that were
restricted to diabetic participants. The interactions were stronger in persons who reported medication
use where mean ∆HbA1c changed by 0.90% (0.31, 1.49%) in diabetic participants on medication with
high MGRS, and by −0.32% (−0.50, −0.14%) per 10 dB, in those with low MGRS (Pinteraction = 0.001)
(Figure 2). All single variants showed positive interaction with RTN in diabetic participants. The lead
functional variant, rs10830963, showed the strongest significant interactions, where mean ∆HbA1c
increased by 0.80% (0.14, 1.47%) and by 1.21% (0.59, 1.83%) per 10 dB and per risk allele, in diabetics
and medicated diabetics, respectively (Table 3).
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Figure 2. Modification of the association between night-time road traffic noise and change in HbA1c
by melatonin dysregulation risk score, in non-movers.
Interaction terms included night-time road traffic noise and MTNR1B variants/score. MTNR1B
score represents the sum of the risk alleles across six included variants. Positive sign of beta coefficient
means increase in HbA1c per 10 dB change in night-time road traffic noise and per risk allele.
All models were adjusted for age, sex, education, neighborhood socio-economic index, smoking
status, passive smoking, alcohol consumption, green space within a 2 km residential buffer, residential
levels of nitrogen dioxide, night-time railway, aircraft noise, and their truncation indicators. All models
included random intercepts at the level of the study areas, and were corrected for potential selection
bias by applying the probability of participation in present analyses as weights derived from a logistic
regression with predictors from the baseline study in 1991.
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Table 3. Interaction between MTNR1B variants (single/score) and night-time road traffic noise (10 dB difference) on change in HbA1c, in non-movers.
MTNR1B Variant Risk/Other
Allele
Risk Allele
Frequency
All
N = 2142
No Diabetes
N = 1960
Diabetes
N = 179
Diabetes on Medication
N = 117
β Interaction Term
(95% CI)
β Interaction Term
(95% CI)
β Interaction Term
(95% CI)
β Interaction Term
(95% CI)
rs1387153 a T/C 0.30 0.04 (−0.02, 0.10) 0.01 (−0.01, 0.02) 0.66 (0.17, 1.15) * 0.92 (0.45, 1.39) †
rs1387153 b T/C 0.30 0.04 (−0.02, 0.10) 0.01 (−0.01, 0.02) 0.67 (0.17, 1.18) * 0.92 (0.44, 1.40) †
rs10830962 a G/C 0.42 0.03 (−0.02, 0.09) −0.003 (−0.02, 0.01) 0.56 (0.18, 0.95) * 0.83 (0.26, 1.39) *
rs10830962 b G/C 0.42 0.03 (−0.02, 0.09) −0.003 (−0.02, 0.01) 0.57 (0.18, 0.96) * 0.83 (0.21, 1.46) *
rs4753426 a C/T 0.49 0.01 (−0.05, 0.07) −0.01 (−0.04, 0.02) 0.30 (−0.19, 0.80) 0.42 (−0.01, 0.85) ‡
rs4753426 b C/T 0.49 0.01 (−0.05, 0.07) −0.01 (−0.04, 0.02) 0.31 (−0.18, 0.80) 0.42 (0.01, 0.83) *
rs8192552 a G/A 0.93 −0.001 (−0.06, 0.05) −0.02 (−0.05, 0.02) 0.31 (−0.52, 1.15) 0.28 (−0.41, 0.98)
rs8192552 b G/A 0.93 −0.001 (−0.05, 0.05) −0.02 (−0.05, 0.02) 0.31 (−0.52, 1.14) 0.28 (−0.45, 1.01)
rs10830963 a G/C 0.29 0.04 (−0.03, 0.10) −0.004 (−0.02, 0.02) 0.80 (0.16, 1.45) * 1.21 (0.62, 1.78) †
rs10830963 b G/C 0.29 0.04 (−0.03, 0.10) −0.004 (−0.02, 0.02) 0.80 (0.14, 1.47) * 1.21 (0.59, 1.83) †
rs3781638 a T/G 0.55 0.01 (−0.06, 0.07) −0.002 (−0.04, 0.03) 0.18 (−0.17, 0.54) 0.32 (−0.08, 0.71) ‡
rs3781638 b T/G 0.55 0.01 (−0.05, 0.07) −0.002 (−0.04, 0.03) 0.18 (−0.17, 0.54) 0.31 (−0.06, 0.69) ‡
MTNR1B score a 0.01 (−0.01, 0.02) −0.001 (−0.01, 0.004) 0.15 (0.01, 0.30) * 0.23 (0.10, 0.36) *
MTNR1B score b 0.01 (−0.01, 0.02) −0.001 (−0.01, 0.004) 0.15 (0.01, 0.30) * 0.23 (0.10, 0.37) *
MTNR1B score >6 vs. ≤6 § a 0.07 (−0.01, 0.15) ‡ 0.01 (−0.01, 0.03) 0.87 (0.38, 1.36) † 1.25 (0.70, 1.80) †
MTNR1B score >6 vs. ≤6 § b 0.07 (−0.01, 0.15) ‡ 0.01 (−0.02, 0.04) 0.87 (0.38, 1.37) † 1.25 (0.68, 1.83) †
§ + Short Form-36 mental health|| a 0.07 (−0.01, 0.15) ‡ 0.02 (−0.02, 0.06) 0.82 (0.36, 1.28) † 1.11 (0.76, 1.46) †
§ + Short Form-36 mental health|| b 0.07 (−0.01, 0.15) ‡ 0.02 (−0.02, 0.06) 0.81 (0.36, 1.27) † 1.12 (0.74, 1.49) †
a Adjusted model without BMI; b Adjusted model with BMI; § MTNR1B score > 6 vs. ≤6 model; * p < 0.05; † p < 0.001; ‡ p < 0.1. || N(all) = 1865; N (no diabetes) = 1711; N(diabetes) = 152;
N (diabetes on medication) = 99.
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Although we observed statistically significant associations between RTN and mean ∆HbA1c
among non-diabetic participants with high MGRS, the difference in associations between non-diabetic
participants with high and low MGRS was non-significant (Pinteraction = 0.39) (Figure 2).
All results are presented as increase or decrease in mean change in HbA1c per 10 dB of night-time
road traffic noise. MTNR1B genetic risk score represents the sum of risk alleles across six included
MTNR1B variants. All models were adjusted for age, sex, education, neighborhood socio-economic
index, smoking status, passive smoking, alcohol consumption, body mass index, green space within a
2 km residential buffer, residential levels of nitrogen dioxide, night-time railway, aircraft noise and their
truncation indicators. All models include random intercepts at the level of the study areas, and were
corrected for potential selection bias by applying the probability of participation in present analyses as
weights derived from a logistic regression with predictors from the baseline study in 1991.
The interactions between RTN and MGRS did not significantly differ by sex in both diabetic and
non-diabetic participants (Pinteraction ≥ 0.30). Similar to the main models, interaction models were also
very stable to adjustments for BMI (Table 3). Even though the direction of interaction terms in models
including all participants was generally similar to those in non-movers, the magnitude of interactions
was smaller, and the interaction terms in those models were not statistically significant (Table S3).
3.5. Sensitivity Analyses
Our results were robust to sensitivity analyses, including complete case analyses without
correction for potential selection bias, as well as RTN–MGRS interaction analyses excluding asthmatic
participants Sensitivity analyses limited to participants whose bedrooms were oriented towards
the street also showed very similar results. Interactions with self-reported sleep insufficiency
were consistent in diabetic participants, reaching significance among those on medication. Unlike
with MGRS, we observed significant interaction with self-reported sleep sufficiency in non-diabetic
individuals (Table 4).
MTNR1B score represents the sum of risk alleles across six included variants. All estimates
represent an increase (+) or decrease (−) in mean change in HbA1c per 10 dB of night-time road traffic
noise. Adjusted models included age, sex, education, neighborhood socio-economic index, smoking
status, passive smoking, alcohol consumption, body mass index, green space within a 2 km residential
buffer, residential levels of nitrogen dioxide, night-time railway, aircraft noise, and their truncation
indicators. All models include random intercepts at the level of the study areas, and were adjusted
for potential selection bias by applying the probability of participation in present analyses as weights
derived from a logistic regression with predictors from the baseline study in 1991. NA: not applicable.
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Table 4. Sensitivity analyses on the association between night-time road traffic noise and change in HbA1c, in non-movers.
Model Categories
All
N = 2142
No Diabetes
N = 1960
Diabetes
N = 179
Diabetes on Medication
N = 117
β (95% CI) β (95% CI) β (95% CI) β (95% CI)
Main model corrected for potential selection
bias NA 0.02 (0.003, 0.04) * 0.01 (0, 0.03) * 0.03 (−0.14, 0.19) 0.10 (−0.09, 0.29)
Complete case analyses: Adjusted model NA 0.02 (−0.002, 0.05) † 0.02 (0, 0.04) * 0.03 (−0.21, 0.28) 0.05 (−0.28, 0.37)
Complete case analyses: Stratification by
MTNR1B score
≤6 −0.01 (−0.04, 0.03) 0.01 (−0.01, 0.04) −0.34 (−0.64, −0.04) * −0.40 (−0.76, −0.05) *
>6 0.06 (0.02, 0.09) * 0.03 (0.001, 0.05) * 0.49 (0.16, 0.82) * 0.81 (0.37, 1.26) ‡
P-value of interaction <0.01 0.48 <0.001 <0.001
Main model excluding participants whose
bedrooms did not face the street:
Stratification by MTNR1B score
≤6 0.01 (−0.03, 0.04) 0.02 (−0.01, 0.05) −0.19 (−0.39, −0.003) * −0.02 (−0.38, 0.34)
>6 0.07 (0.01, 0.13) * 0.03 (−0.001, 0.06) 0.49 (0.08, 0.90) * 0.85 (0.23, 1.47) ‡
P-value of interaction 0.14 0.42 <0.001 <0.001
Main model excluding asthma cases:
Stratification by MTNR1B score
≤6 −0.01 (−0.03, 0.02) 0.004 (−0.02, 0.03) −0.26 (−0.48, −0.03) * −0.30 (−0.53, −0.07) *
>6 0.06 (−0.003, 0.11) * 0.02 (−0.004, 0.05) * 0.50 (0.07, 0.92) * 0.98 (0.35, 1.61) *
P-value of interaction 0.07 0.39 0.001 <0.001
Main model: Stratification by self-reported
insufficient sleep
No −0.002 (−0.03, 0.02) −0.001 (−0.02, 0.02) −0.08 (−0.28, 0.15) −0.11 (−0.36, 0.14)
Yes 0.07 (0.02, 0.14) * 0.05 (0.004, 0.09) * 0.28 (−0.13, 0.69) 0.67 (0.11, 1.23) *
P-value of interaction 0.092 0.059 0.2 0.029
* p < 0.05; † p < 0.1; ‡ p < 0.001.
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4. Discussion
We found positive associations between exposure to RTN and eight-year change in HbA1c in
non-movers, which were significantly stronger among diabetic individuals at genetic risk of circadian
rhythm disturbances. We also found positive associations with aircraft noise that were again stronger
in diabetics. Railway noise was not associated with change in HbA1c, supporting findings from
previous studies where road traffic and aircraft noise, but not railway noise [12,13] was associated
with diabetes risk.
Melatonin is involved in the regulation of human circadian rhythms through its role in
thermoregulation and sleep induction [17]. The secretion of melatonin occurs during the biological
night, in a fasting state, when insulin secretion is low [52]. Therefore, the melatonin pathway may
play a role in noise susceptibility if noise exposure causes early awakenings and potential early meals,
which could stimulate insulin secretion during high melatonin levels, leading to impaired glucose
tolerance [22,53]. Diabetics with high MGRS had higher mean BMI (31 kg/m2) compared to those with
low MGRS (29 kg/m2). Noise could also delay sleep onset [54], possibly leading to later chronotype
which was associated with metabolic disturbances and diabetes [23,55]. We found supportive evidence
for this hypothesis only in diabetic participants. One explanation for this may be that individuals
with diabetes usually have comorbidities and worse homeostatic mechanisms, and are more prone to
environmental stressors [56,57]. Exposure to high traffic volume was shown to have a stronger impact
among diabetic individuals on insulin, which could imply more complicated diabetes, expressing
higher inflammatory profiles compared to those on oral hypoglycemic agents [58]. Participants using
diabetic medication in this study were more likely to be overweight, to have cardiovascular diseases
and higher C-reactive protein levels compared to the other participants. Diabetic individuals with a
high genetic risk for melatonin profile dysregulation may be particularly sensitive to poor glucose
homeostasis. Diabetic individuals have also been shown to have sleep–wake cycle irregularities
compared to non-diabetics [59,60]. Our finding of a significant negative effect of noise on glycemia
among diabetics with low MGRS is surprising. Although this could be a chance finding, diabetics
with low MGRS had lower average night-time noise exposure (46 dB), and were less noise sensitive
(45%) compared to those with high MGRS (48 dB noise level and 51% noise sensitivity). Diabetic
participants with low MGRS potentially have better melatonin profiles, and could be at lower risk
for noise disturbances. The complexity of the melatonin system in influencing several physiological
processes [24] calls for more research to better understand this finding.
Our observation of interaction of RTN with self-reported sleep insufficiency, but not with genetic
risk for melatonin profile dysregulation on ∆HbA1c in non-diabetic individuals, suggests that the
melatonin pathway may not be relevant in this group. Interestingly, noise-induced sleep disruption
was reported to impair glucose homeostasis through non-melatonin pathways, including the activation
of sympathetic nervous system and release of stress-related hormones [61]. As GWAS continues to
identify more circadian-related variants, future studies should consider variants covering the entire
circadian pathways, and also incorporate objective sleep and stress-related parameters to improve
understanding of the cardiometabolic effects of noise.
Since night-time noise levels were correlated to Lden, we may not exclude the contributions of
day-time noise exposure (potentially via the stress pathway) to our observations. Noise, through
stress/anxiety, may reduce adherence to medication in diabetic individuals, worsening their glucose
control [62,63]. Exploratory analyses among the respondents to the SF-36 mental health survey [32]
showed a reduction in the magnitude of the observed interactions (in diabetic participants) following
adjustment for their mental health scores (Table 3).
The strengths of this study derive from its novelty in applying gene–environment interactions to
better understand the impact of noise on glucose control in a longitudinal design, and the availability
of detailed phenotypic and genotypic information in the SAPALDIA study. Information on medication
use allowed the exploration of different diabetes phenotypes. We could test the hypothesis covering a
potential pathway of glycemic effects of noise exposure, and used validated models with high spatial
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resolutions to assign individual estimates of noise and air pollution. The availability of information
on change of residence allowed focusing analyses on non-movers, allowing the use of baseline noise
levels as long-term exposures towards our health outcome.
Although our study is limited by sample size which calls for cautionary interpretation, we
controlled for potential selection bias and made salient findings which could be generalized to all
non-movers in the study period. Potentially, post-transcriptional/translational modifications may
have affected melatonin profile, hence the absence of a risk variant may not imply normal melatonin
profiles, and vice versa. We also lack information on melatonin drug use by the participants. However,
the lack of correlation (R = 0.01) between self-reported sleep insufficiency and MGRS in our study
corroborates the findings of previous studies where the lead MTNR1B variant was not associated
with sleep duration [22,64], validating our application of MGRS in this study. We did not have
adequate nutrient intake information e.g., antioxidant or fiber intake. Adjustment for nutrients may
be considered an over-adjustment, if part of the noise–HbA1c association is mediated by impact of
noise on food preference. Although our noise estimates were from validated models, some degree
of misclassification will have occurred due to errors in input data. We did not have information on
participants’ work shifts in our noise exposure models. However, the resulting bias is more likely
non-differential, and to bias effect estimates towards null. We did not consider window opening
habits which may be related to exposure level, and could have also biased our estimates towards
null. Since we found significant associations in non-movers, we cannot generalize our findings to all
SAPALDIA participants. Noise exposure metrics were significantly different between movers and
non-movers, with a tendency for movers to move to areas with lower RTN (Table S6). This tendency
per se, might have led to an over-estimation of the noise effects among movers if there had been no
random misclassification. However, the total bias is the sum of any bias associated with differential
misclassification, and the attenuation bias associated with random misclassification. Although we
cannot prove it, we are quite convinced that the attenuation bias had a stronger impact on our results
than any potential bias due to differential misclassification.
5. Conclusions
Our findings raise the hypothesis that genetic risk for melatonin profile dysregulation,
in combination with long-term road traffic noise, better captured in non-movers, may increase the risk
for poor glucose homeostasis, particularly in diabetic patients. While our findings need replication
and confirmation in other independent cohorts, experimental interventional studies should test the
hypothesis to determine if counseling for noise control should be added to diabetes care.
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